Inactive Instrument

BERI GROU Stock Deutsche Boerse AG

Beroni Group Limited is an Australia-based international biopharmaceutical company. The Company is focused on biomedicine, artificial intelligence, and modern technology research and development. Its businesses include cell therapies, developing new anti-cancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and the detection and diagnosis of infectious diseases. Its technology includes Brain Wave Extraction patent technology, a foundational technology in the Brain-Computer Interface (BCI) field, that enables the acquisition of high-resolution electroencephalogram (EEG) signals using a minimal number of electrodes, significantly enhancing the practicality and portability of BCI systems. Its product offering includes NicoBloc, CII-ArboViroPlex rRT-PCR assay and stem cell cosmetic products, including AGG Skin-Smoothing and Anti-Wrinkle Facial Mask, ODd Skin Repair Essence, ODd Beroni Beauty Facial Mask, and others.

Employees

Sector

Pharmaceuticals

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	336K 234K 205K 189K 175K 330K 22.52M 2.26M 886K 11.03M 881K 861K 37.97M	P/E 2024	-2.72x	P/E 2025	-0.07x
Enterprise Value	1.71M 1.19M 1.04M 964K 891K 1.68M 115M 11.5M 4.51M 56.14M 4.48M 4.38M 193M	EV / Sales 2024	109x	EV / Sales 2025	2.68x
Free-Float	21.57%	Yield 2024 *	-	Yield 2025	-

07-06	Beroni Guangdong Pharmaceuticals Achieves Four Major Preclinical Milestones Advancing Global Licensing-Ready Drug Platforms	CI
03-31	Beroni Group Limited Auditor Raises 'Going Concern' Doubt	CI
03-12	Beroni Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12/09/25	Beroni Group Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI
21/07/25	Beroni Pharmaceuticals Co., Ltd. Announces Significant Breakthrough in Building Its Nucleic Acid Innovative Drug Platform	CI

01/06/22	Beroni Group’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification	GL
02/03/21	Beroni Group Limited (NSX:BTG) Appointment of Non-Executive Director	AQ
03/02/21	BERI GROU : Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company	AQ
03/02/21	Beroni Group Limited (NSX:BTG) Acquires Majority Interest in Anti-Cancer Drug Development Company	AQ
10/11/20	BERI GROU : Beroni Group Launches a New Probiotics Health Product in China	AQ

Manager	Title	Age	Since
Bo Qing Zhang CEO	Chief Executive Officer	57	17/06/2016
Yap Ting Wong DFI	Director of Finance/CFO	64	02/07/2018
Chen Chik Ong SEC	Corporate Secretary	47	01/03/2021

Director	Title	Age	Since
Bo Qing Zhang CHM	Chairman	57	17/06/2016
Hai Huang BRD	Director/Board Member	59	03/11/2016
Li Bing Guo BRD	Director/Board Member	55	03/11/2016

BERI GROU Stock Deutsche Boerse AG

Stocks

Pharmaceuticals

Valuation: BERI GROU

Latest news : BERI GROU

Press Releases: BERI GROU

Managers and Directors: BERI GROU

Other Pharmaceuticals

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BERI GROU	-.--%	-3.81%	-	-	218K
ELI LILLY AND COMPANY	-2.19%	-6.34%	+44.78%	+157.48%	1,054B
JOHNSON & JOHNSON	-1.98%	-5.11%	+61.71%	+58.62%	621B
ABBVIE INC.	-1.00%	-3.70%	+28.04%	+80.30%	438B
ROCHE HOLDING AG	-1.12%	-3.68%	+26.89%	+20.58%	325B
NOVARTIS AG	-1.73%	-3.45%	+26.95%	+44.09%	281B
ASTRAZENECA PLC	-1.95%	-13.92%	+15.96%	+19.76%	262B
NOVO NORDISK A/S	-1.45%	-2.37%	-27.87%	-39.87%	219B
AMGEN INC.	-0.98%	-3.05%	+20.15%	+56.92%	195B
GILEAD SCIENCES, INC.	-0.38%	-4.10%	+16.67%	+69.41%	163B
Average	-1.31%	-1.70%	+23.70%	+51.92%	395.13B
Weighted average by Cap.	-1.69%	-1.69%	+33.40%	+77.45%

	2024	2025
Net sales	317K 221K 193K 179K 165K 311K 21.27M 2.13M 837K 10.41M 832K 813K 35.86M	638K 446K 390K 360K 333K 627K 42.84M 4.3M 1.69M 20.98M 1.68M 1.64M 72.24M
Net income	-10.61M -7.41M -6.48M -5.99M -5.53M -10.42M -712M -71.41M -28.02M -349M -27.84M -27.23M -1.2B	-4.22M -2.95M -2.58M -2.38M -2.2M -4.15M -283M -28.43M -11.16M -139M -11.09M -10.84M -478M
Net Debt	-254K -178K -155K -144K -133K -250K -17.08M -1.71M -672K -8.36M -668K -653K -28.8M	1.37M 959K 838K 775K 716K 1.35M 92.12M 9.24M 3.63M 45.11M 3.6M 3.52M 155M